胺作为桥梁疗法:减少医院环境中的急性自杀倾向
Paul E Lie1,2,3, Titus Y Lie4, Madeleine Nguyen5
1School of Medicine, Texas Tech University Health Sciences Center (TTUHSC), Lubbock, TX 79430, USA.
Healthcare (Basel, Switzerland)
|March 14, 2026
概括
胺可以快速缓解急性自杀倾向,可能弥合SSRI留下的治疗差距. 需要进一步的临床研究来验证这种胺桥疗法,以便广泛采用.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 自杀率的上升是一个严重的公共卫生挑战.
- 标准的SSRI抗抑郁药在缓解症状方面有显著的延迟 (2-6周),造成了危险的滞后期.
- 胺,一个NMDA受体对手,显示出快速抗抑郁作用的潜力.
研究的目的:
- 为了探索胺桥疗法对急性自杀倾向的假设框架.
- 为了评估胺胺在缓解SSRI治疗延迟方面的潜力.
- 在这种情况下,综合现有关于胺的疗效和安全性的证据.
主要方法:
- 叙事文学评论. 叙事文学评论. 叙事文学评论. 叙事文学评论.
- 搜索了PubMed,谷歌学者,科克兰图书馆和PsycINFO (2000年1月至2025年12月).
- 综合了关于SSRI延迟,胺蛋白协议和放电后安全性的证据.
主要成果:
- 胺的作用机制 (mTORC1) 比SSRI更快,可能缩短缓解症状的延迟时间.
- 在临床环境中控制的,低麻醉剂量的胺似乎具有较低的滥用潜力.
- 有证据表明,胺可以有效地弥合SSRI治疗延迟期间的差距.
结论:
- 胺桥疗法是治疗急性自杀倾向的一个有希望的概念.
- 在广泛采用之前,需要严格的纵向验证和持续的临床研究.
- 进一步的研究是必要的,以确定长期使用的安全性和有效性.
相关概念视频
01:30Electroconvulsive Therapy
1.7K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.7K
01:24Parenteral Anesthetics: Overview
865
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
865
01:28Drug Therapy
364
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
364
01:19Depolarizing Blockers: Pharmocokinetics
691
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
691
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
775
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
775
01:26Psychosis: Goals of Pharmacotherapy
649
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
649